drugset / Trial / NCT03814954

Nebulized Epinephrine vs. Salbutamol in Bronchiolitis Among Children

NCT03814954

Completed 90 enrolled Makassed General Hospital
RandomizedParallel-groupSingle-blindTreatment

Summary

Acute bronchiolitis, mostly secondary to infection due to Respiratory syncytial virus (RSV) is very common in infants under two years old. It is usually benign. However, the dyspnea it causes is a big concern for parents and this disease can take a severe form on certain particular ground thus constituting a frequent reason for hospitalization in pediatrics. Nebulized epinephrine showed more efficacy than nebulized salbutamol.

Timeline

Start
2019-01-01
Primary completion
2021-08-31
Completion
2021-08-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Epinephrine Other / unclassified 0.5 mg Other
Comparator Salbutamol Unknown 2 iu/kg Other

Indications

No indication recorded.